JENNIFER FLEMING: Open Payments
NPI 1801219829 · LAWRENCE, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$79,260 in 80 payments from 2 companies in 2025. Trend: 2023 $0 · 2024 $340 · 2025 $79,260
Speaker / faculty: $74,250Travel & lodging: $3,774Food & beverage: $1,237
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 79 | $79,246 |
| Gilead Sciences, Inc. | 1 | $14 |
Products named: DAXXIFY, DAXI.
Industry payments across MA — which companies pay providers there.
